The effect of treatment due to smoking at cancer patients discovered the study conducted by Delhi AIIMs - NCR -smoking reduces the effectiveness of cancer treatment.

The effect of treatment with smoking at cancer patients, Delhi AIIMs discovered in a study conducted with many countries and international experts, described the need to register a smoking status in the treatment of cancer. The consumption of tobacco products can reduce the effectiveness of the treatment and survival rate of the patient. The study found that the dose of the drug should be doubled in patients who continue to smoke. Therefore, it is mandatory to record the condition of smoking during cancer treatment. The effect of treatment with smoking at cancer patients. Jagran correspondent, New -Delhi. Experts of Aiims Delhi, the Canadian -based McMaster University and France -based International Cancer Research Agency (IARC), described the need to register a state of smoking during the treatment of cancer. Experts have warned that the regular intake of tobacco products could reduce the effectiveness of treatment and the patient’s survival rate. The study was published by Lancet Oncology this month. In the study, seven writers, including Dr. Abhishek Shankar of Aiims Delhi, suggested that information on reddish conditions may affect medical decisions during treatment. Argued that the inclusion of the obstacles in assessing tobacco use in the oncology research protocol will improve the results of the test. Medical effectiveness will also increase and life will be saved. The study revealed that the dose of Erlotinib in patients who continue to smoke should be doubled (from 150 mg to 300 mg per day) to get medical benefits. That is, the consumption of persistent tobacco products can affect the digestive, therapeutic reaction and long -term results of the drug. Therefore, the registration of the state of smoking during cancer treatment is no longer alternative, but should be considered a substantial element of cancer research.